C/ BASE NO CPA 2023_491
TED · 768914-2026Award noticeawardedNo deadline given
Value
Estimated—
Awarded—
WinnerCENCORA 3PL PORTUGAL, S.A. | AMGEN - BIO-FARMACÊUTICA, LDA. | SANDOZ FARMACÊUTICA, LDA. | ROCHE FARMACÊUTICA QUÍMICA, LDA. | Farmoz - Sociedade Técnico-Medicinal, S.A | Sermail — Logística Integrada, Lda. | Pierre Fabre Médicament Portugal, Lda. | Bayer Portugal, Lda. | TAKEDA - FARMACÊUTICOS PORTUGAL, LDA. | ASTELLAS FARMA, LDA. | LEO Farmacêuticos, Limitada
Who already wins at this buyer
Firms with recorded awards from Unidade Local de Saúde de Coimbra, EPE in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| Brainlab Sales GmbH | 2 | €2,619,329 | 2026-10-08 |
| Cencora 3PL Portugal, S.A. | 2 | €1,435,097 | 2026-10-28 |
| ROCHE FARMACÊUTICA QUÍMICA, LDA. | 2 | €1,240,039 | 2026-10-29 |
| Cencora 3Pl Portugal, S.A. | 2 | €823,396 | 2026-10-27 |
| Roche Farmacêutica Química, Lda. | 2 | — | 2026-10-08 |
Full buyer profile: what Unidade Local de Saúde de Coimbra, EPE buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
Aquisição de medicamentos C/ BASE NO CPA 2023_491
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-09-09 | C/ BASE NO CPA 2023_481 - AXICABTAGENE CILOLEUCEL 0.4 - 2 X10E8 CÉLULAS DISP INJ FR 68 ML IV | Unidade Local de Saúde de Coimbra, EPE PT | 93% |
| 2026-10-08 | C/ BASE NO CPA 2025_1303 - OCRELIZUMAB 920 MG/23 ML SOL INJ FR 23 ML SC | Unidade Local de Saúde de Coimbra, EPE PT | 93% |
| 2026-09-09 | C/ base no CPA 2023_368 - cloro-hexidina 0.2% gel bucal bisn 40 ml | Unidade Local de Saúde de Coimbra, EPE PT | 93% |
| 2026-09-09 | C/ base no CPA 2023_671 - Foslevodopa 240 mg/ml + Foscarbidopa 12 mg/ml sol inj fr 10 ml sc | Unidade Local de Saúde de Coimbra, EPE PT | 92% |
| 2026-08-17 | C/ BASE NO CPA 2024_900 - LAMIVUDINA 300 MG + DOLUTEGRAVIR 50 MG COMP | Unidade Local de Saúde de Coimbra, EPE PT | 92% |
| 2026-09-17 | C/ BASE NO CPA 2025_1746 - TREPROSTINILO 10 MG/ML SOL INJ FR 10 ML IV SC | Unidade Local de Saúde de Coimbra, EPE PT | 92% |